Medical-Grade Polyamide 12 Nanocomposite Materials for Enhanced Mechanical and Antibacterial Performance in 3D Printing Applications

During the COVID-19 pandemic, wide use of 3D printing technologies has been enabled. Fused filament fabrication (FFF) is the most widely used technique in 3D printing communities worldwide for the fabrication of medical components such as face shields and respiratory valves. In the current study, the potential of Polyamide 12 (PA12) silver-doped antibacterial nanopowder (AgDANP) nanocomposites is evaluated for everyday FFF usage. Filling loadings of 1.0-2.0-3.0 and 4.0 wt.% were selected for nanocomposite preparation. Mechanical performance analysis was conducted on the basis of tensile, flexural, impact, and Vickers microhardness measurements in FFF 3D-printed specimens. Scanning Electron Microscopy (SEM) images were used for morphology and processing evaluation, as well as thermal performance measurements, conducted by Thermogravimetric Analysis (TGA) tests. Finally, the antibacterial performance was tested using the agar-well diffusion screening method, and the shape effect of the specimens was also investigated. The addition of 2.0 wt.% AgDANPs resulted in an enhancement of approximately 27% for both tensile and flexural stresses, while the antibacterial performance was sufficiently high among the nanocomposites tested. The shape effect exhibited the potential for antibacterial performance at low filling ratios, while the effect was diminished with increasing filler of AgDANPs.